Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Fears of ageing may cause earlier death, says UN
29 Sep 2016 at 7:16am
Being afraid of growing old may shorten your life, the UN health agency said Thursday, as new data highlighted the widespread prevalence of ageist attitudes worldwide. The data confirms "that ageism is extremely common," said John Beard, WHO's head of Ageing and Life Course. "There is very good evidence that people who have negative views of themselves as they grow older... it shortens their lives," Beard told reporters.
Amgen, Arrowhead team up on gene-therapies for heart disease
29 Sep 2016 at 7:15am
Amgen Inc said on Thursday it would buy a stake in Arrowhead Pharmaceuticals Inc and collaborate with the company to develop gene-silencing therapies for heart disease. Arrowhead will get $35 million up front and a $21.5 million injection from Amgen that will give the world's No. 1 biotech company by market value an equity stake of 4.5 percent. Pasadena, California-based Arrowhead will also eligible for up to $617 million in further milestone and equity payments.
Sculptor Antony Gormley creates labyrinth for new London show
29 Sep 2016 at 6:59am
British sculptor Antony Gormley puts people's relationships with urban construction at the forefront of his latest exhibition "Fit", creating a sort of labyrinth in a London gallery space. "Sleeping Field", one of the installations at the White Cube Bermondsey gallery, is made up of hundreds of iron sculptures, which at first look like small high-rise buildings but on closer inspection resemble resting bodies. "Fit" follows the Turner Prize winning artist's "Model" exhibition with a concept that "considers the degree to which we are measured by and measure ourselves against the scale and density of our built environment".
Herbal supplement maker agrees to quality control measures
29 Sep 2016 at 6:43am
ALBANY, N.Y. (AP) ? New York's attorney general says the state has reached an agreement with an herbal supplement maker to implement new quality control measures to confirm the authenticity of its products.
Horizon Pharma to pay Express Scripts $65 million to settle rebate litigation
29 Sep 2016 at 6:36am
(Reuters) - Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines. Express Scripts, the largest manager of U.S. drug benefits, in November sued Horizon for a breach of contract, seeking $166.2 million in rebates related to Duexis, Rayos and Vimovo. Horizon contested the claim and contended that Express Scripts had breached the rebate agreement.
Colombia tipped for Nobel Peace Prize after deal to end war
29 Sep 2016 at 6:27am
By Alister Doyle and Jessica Jaganathan OSLO (Reuters) - A Colombian peace accord ending a half-century of war is widely tipped for the Nobel Peace Prize next week, returning the award to its roots after a run of wins for organizations including the European Union. The prize might be shared by President Juan Manuel Santos and Marxist FARC rebel leader Timochenko - the nom de guerre of Rodrigo Londono - after they signed a deal on Sept. 26 to end a war that killed a quarter of a million people. "The agreement ... is one of the most obvious peace prize candidates I've ever seen," said Asle Sveen, a historian who tracks the awards.
Schedule of Nobel Prize 2016 announcements
29 Sep 2016 at 6:27am
STOCKHOLM (Reuters) - Sweden's annual crop of Nobel Prizes for achievements in science, literature and peace is announced in the coming days, beginning with the medicine prize. Oct. 3 Nobel Prize in Physiology or Medicine (announced in Stockholm at 0930 GMT at the earliest) Oct. 4 Nobel Prize in Physics (announced in Stockholm at 0945 GMT at the earliest) Oct. 5 Nobel Prize in Chemistry (announced in Stockholm at 0945 GMT at the earliest) Oct. 6 (possible date) Nobel Prize in Literature (according to tradition, the exact date for this prize is only announced shortly before it is presented. ...
California shooting shows police ill-equipped to handle mentally ill
29 Sep 2016 at 6:23am
Alfred Olango, 38, a Ugandan-born immigrant, was shot by one officer even as another, who had been trained to deal with mentally ill people, attempted to subdue him with a Taser, police said. The confrontation in the San Diego suburb of El Cajon came at a time when San Diego County is facing a doubling of mental health-related calls since 2009, officials said, tracking the impact of decades of tight budgets for mental health services. "This is a systemic issue across the country," said Maggie Merritt, executive director of the Steinberg Institute, a mental health policy research and advocacy group in Sacramento.
Identical girl triplets born in Poland are doing well
29 Sep 2016 at 6:21am
WARSAW, Poland (AP) ? A spokeswoman for a hospital in southwestern Poland says extremely rare identical girl triplets were born earlier this month through a cesarean section and are doing well.
Drug Overdose Deaths Drive Increase in Number of Organ Donations: One Family?...
29 Sep 2016 at 6:05am
Mother finds "family" in man who received son's liver.
Did landmark laws from Congress enable high drug prices?
29 Sep 2016 at 6:05am
Lawmakers are venting outrage over high prescription drug costs, but if Congress is looking for culprits, it might want to look in the mirror. Republican- and Democratic-controlled Congresses, and presidents ...
After CEO move, GSK picks ex-Novartis exec to head consumer unit
29 Sep 2016 at 5:25am
GlaxoSmithKline has promoted a former Novartis executive to lead its consumer healthcare business, following the appointment last week of the unit's previous head, Emma Walmsley, as CEO designate of the drugmaker. The British group said on Thursday that Brian McNamara, 50, who currently heads up Europe and the Americas at GSK Consumer Healthcare, would take on his new role immediately and join GSK's corporate executive team. McNamara worked for 11 years at Novartis, where he was also in charge of consumer health, and joined GSK following the creation of a joint venture between the two companies in 2015.
'Cancer hotels' house China's patient refugees
29 Sep 2016 at 4:44am
By Kim Kyung Hoon BEIJING (Reuters) - In the shadow of one of China's top cancer hospitals in Beijing, a catacomb-like network of ramshackle brick buildings has become a home-from-home for hundreds of cancer patients and their families waiting for treatment. The cluster of nine buildings, connected by dark, narrow passageways, offers cheap accommodation for patients unable to afford a coveted hospital room, a reflection of the vast inequalities in China's overburdened healthcare system. Good doctors don't want to work in small places," said Liu, 46, a migrant worker who brought his wife more than 750 km (450 miles) to see a specialist in the capital in May. His wife, Wang, 42, was diagnosed with cervical cancer at the beginning of the year, and was told by family she should leave her hometown in Inner Mongolia for treatment.
Japan conglomerates seek to merge loss-making nuclear fuel operations: sources
29 Sep 2016 at 3:19am
Three Japanese conglomerates are in talks to combine their loss-making domestic nuclear fuel operations, people with direct knowledge of the matter said, as the outlook for restarts of reactors following the Fukushima nuclear crisis remains bleak. Hitachi Ltd , Toshiba Corp and Mitsubishi Heavy Industries Ltd aim to merge the operations as early as spring 2017, one of the people said, declining to be identified as the discussions were confidential. The person added that the three companies may eventually consider merging their nuclear reactor businesses, although nothing specific has been discussed so far.
Painkillers linked to heart failure: study
29 Sep 2016 at 1:52am
Widely used prescription and non-prescription painkillers are associated with an increased risk of hospital admission for heart failure, according to a study released Thursday. The drugs in question are so-called NSAIDs, or non-steroidal anti-inflammatory drugs, including several known as COX-2 inhibitors. The broad link between the use of NSAIDs and heart failure is well established, but which drugs pose the greatest risk, and at what doses, remains poorly understood.